I'm not quite sure what to make of Tim's comment. The comment in general seems negative, but I don't understand what he would mean by saying with "due to lower cell from limited umbilical cord blood". Is he just stating the fact that umbilical cord blood has lower cell numbers which is true and thus good regarding the benefit of omidubicel or if he is stating that he thinks there are less cells in the GMDA product. All seems confused.
I then googled GMDA FDA journal June 17 2020 and looked through the FDA website at all the relevant areas and found nothing to do with FDA gmda on June 17th 2020. Did you find anything. Or if you'd be ok with it, can you comment back to Tim, asking for clarification and a source?
Recent GMDAQ News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/10/2024 08:19:25 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/09/2024 08:08:28 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/09/2024 08:04:39 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM